furosemide and bromhexine

furosemide has been researched along with bromhexine in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Glen, RC; Lowe, R; Mitchell, JB1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Fennell, M; Kahler, M; May, L; Railing, FA; Rudy, JA; Sams, R; Shellenberger, J; Soma, LR; Uboh, CE1
Albrich, W; Baumeister, RG; Eiermann, W; Gutschow, K; Luderschmidt, C1
Date, Y; Fujimura, Y; Inoue, H; Kihira, Y; Kojima, E; Kumagai, T; Narahara, N; Ogawa, S; Sato, E; Tsuruta, Y; Yoshitomi, H1

Other Studies

9 other study(ies) available for furosemide and bromhexine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Characterization of bromhexine and ambroxol in equine urine: effect of furosemide on identification and confirmation.
    Journal of pharmaceutical and biomedical analysis, 1991, Volume: 9, Issue:1

    Topics: Ambroxol; Animals; Bromhexine; Chromatography, Thin Layer; Female; Furosemide; Horses

1991
[Cutaneous coumarin necrosis of the breast].
    Deutsche medizinische Wochenschrift (1946), 1983, Sep-16, Volume: 108, Issue:37

    Topics: 4-Hydroxycoumarins; Breast Diseases; Bromhexine; Cimetidine; Female; Furosemide; Humans; Middle Aged; Necrosis; Phenprocoumon; Prednisolone; Pulmonary Embolism; Urticaria; Vasculitis

1983
[Stability of Six Drugs in Total Parenteral Nutrition Solution].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2021, Volume: 141, Issue:4

    Topics: Betamethasone; Bromhexine; Butylscopolammonium Bromide; Drug Packaging; Drug Stability; Famotidine; Furosemide; Metoclopramide; Parenteral Nutrition Solutions; Parenteral Nutrition, Home Total

2021